The First People'S Hospital of Lainyungang
Welcome,         Profile    Billing    Logout  
 7 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jiang, Xiaodong
Endouble, NCT05203276: Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Recruiting
2
40
RoW
Envafolimab, EN WEI DA, Endostar, ENDO
The First People's Hospital of Lianyungang
Lung Neoplasms
05/24
06/24
HB0025-C-01, NCT06758557: A Phase Ib/II Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor

Recruiting
1/2
282
RoW
HB0025, Pemetrexed, Paclitaxel, Carboplatin
Huabo Biopharm Co., Ltd.
Advanced NSCLC, Advanced Endometrial Cancer
10/25
02/26
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies

Recruiting
1/2
1300
Canada, US, RoW
SKB264
Klus Pharma Inc.
Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer
08/25
07/26
NCT06476093: SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer

Recruiting
N/A
46
RoW
Anlotinib hydrochloride, SRT
The First People's Hospital of Lianyungang
Non-Small-Cell Lung Cancer, Brain Metastases
12/26
02/27

Download Options